严重脓毒症患者初始抗菌药物给药时间延长与进展为脓毒性休克相关
该回顾性队列研究纳入656张床位的城市学术医疗中心急诊科≥18岁严重脓毒症和/或脓毒性休克且在24小时内给予抗菌药物的患者,排除就诊时即存在休克者。共识别3929例严重脓毒症患者,总体死亡率12.8%,984例(25.0%)进展为脓毒性休克。进展组初始抗菌药物中位时间为3.77小时(IQR 1.96-6.42),未进展组为2.76小时(IQR 1.60-4.82),差异有统计学意义(p<0.001)。多因素logistic回归显示男性、Charlson合并症指数、感染数量和初始抗菌药物时间与进展相关;初始抗菌药物每延迟1小时,进展风险增加8.0%(OR=1.08,95%CI 1.06-1.10)。广谱抗菌药物时间也与进展相关(OR=1.06,95%CI 1.05-1.08),初始抗菌药物时间还与院内死亡率相关(OR=1.05,95%CI 1.03-1.07)。作者强调急诊严重脓毒症患者早期给予广谱抗菌药物的重要性。
要点
- 急诊严重脓毒症患者初始抗菌药物每延迟1小时,进展为脓毒性休克的风险增加8.0%(OR=1.08,95%CI 1.06-1.10)。
- 进展组初始抗菌药物中位时间3.77小时(IQR 1.96-6.42)vs 未进展组2.76小时(IQR 1.60-4.82),p<0.001。
- 广谱抗菌药物给药时间延长也与进展相关(OR=1.06,95%CI 1.05-1.08)。
- 初始抗菌药物时间与院内死亡率相关(OR=1.05,95%CI 1.03-1.07)。
- 男性(OR=1.18,95%CI 1.01-1.36)、Charlson合并症指数(OR=1.18,95%CI 1.11-1.27)、感染数量(OR=1.05,95%CI 1.02-1.08)与进展相关。
适用人群与场景
- 急诊科≥18岁严重脓毒症和/或脓毒性休克患者,且在24小时内给予抗菌药物;排除就诊时即存在休克者。
研究设计与关键结果
- 回顾性队列研究,纳入656张床位的城市学术医疗中心急诊科患者,共识别3929例严重脓毒症患者,总体死亡率12.8%。
- 984例(25.0%)进展为脓毒性休克。
- 进展组初始抗菌药物中位时间3.77小时(IQR 1.96-6.42)vs 未进展组2.76小时(IQR 1.60-4.82),p<0.001。
- 多因素logistic回归:男性OR=1.18(95%CI 1.01-1.36),Charlson合并症指数OR=1.18(95%CI 1.11-1.27),感染数量OR=1.05(95%CI 1.02-1.08),初始抗菌药物时间OR=1.08(95%CI 1.06-1.10)。
- 初始抗菌药物每延迟1小时,进展为脓毒性休克的风险增加8.0%。
- 广谱抗菌药物时间与进展相关:OR=1.06(95%CI 1.05-1.08)。
- 初始抗菌药物时间与院内死亡率相关:OR=1.05(95%CI 1.03-1.07)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者强调,对于经急诊科收治的严重脓毒症患者,早期给予广谱抗菌药物具有重要意义,因为初始抗菌药物给药时间延长与严重脓毒症进展为脓毒性休克及死亡率增加相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine if time to initial antimicrobial is associated with progression of severe sepsis to septic shock.
DESIGN: Retrospective cohort.
SETTING: Six hundred fifty-six bed urban academic medical center.
PATIENTS: Emergency department patients greater than or equal to 18 years old with severe sepsis and/or septic shock and antimicrobial administration within 24 hours. Patients with shock on presentation were excluded.
INTERVENTIONS: Not available.
MEASUREMENTS AND MAIN RESULTS: We identified 3,929 severe sepsis patients, with overall mortality 12.8%. Nine hundred eighty-four patients (25.0%) progressed to septic shock. The median time to antimicrobial was 3.77 hours (interquartile range = 1.96-6.42) in those who progressed versus 2.76 hours (interquartile range = 1.60-4.82) in those who did not (p < 0.001). Multivariate logistic regression demonstrated that male sex (odds ratio = 1.18; 95% CI, 1.01-1.36), Charlson Comorbidity Index (odds ratio = 1.18; 95% CI, 1.11-1.27), number of infections (odds ratio = 1.05; 95% CI, 1.02-1.08), and time to first antimicrobial (odds ratio = 1.08; 95% CI, 1.06-1.10) were associated with progression. Each hour until initial antimicrobial administration was associated with a 8.0% increase in progression to septic shock. Additionally, time to broad-spectrum antimicrobial was associated with progression (odds ratio = 1.06; 95% CI, 1.05-1.08). Time to initial antimicrobial was also associated with in-hospital mortality (odds ratio = 1.05; 95% CI, 1.03-1.07).
CONCLUSIONS: This study emphasizes the importance of early, broad-spectrum antimicrobial administration in severe sepsis patients admitted through the emergency department, as longer time to initial antimicrobial administration is associated with increased progression of severe sepsis to septic shock and increased mortality.
参考来源
- Whiles BB, Deis AS, Simpson SQ, et al. Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients. Crit Care Med. 2017. PMID: 28169944. doi:10.1097/CCM.0000000000002262
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。